Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Hesham Eissa

Concepts (127)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Hematopoietic Stem Cell Transplantation
15
2026
704
2.980
Why?
Severe Combined Immunodeficiency
8
2026
22
2.790
Why?
Graft vs Host Disease
7
2026
283
1.080
Why?
Cytomegalovirus Retinitis
1
2025
22
0.880
Why?
Cytomegalovirus
1
2025
172
0.820
Why?
Transplantation Conditioning
6
2026
193
0.800
Why?
Immunologic Deficiency Syndromes
3
2026
69
0.570
Why?
Cancer Survivors
5
2021
348
0.490
Why?
Mass Screening
1
2025
1307
0.490
Why?
Positron-Emission Tomography
2
2013
343
0.420
Why?
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
2017
299
0.390
Why?
Burkitt Lymphoma
1
2013
61
0.380
Why?
Fluorodeoxyglucose F18
1
2013
164
0.370
Why?
Lymphoma, B-Cell
1
2013
150
0.350
Why?
Leukemia, Myelomonocytic, Chronic
1
2010
3
0.330
Why?
Histocompatibility
1
2010
20
0.320
Why?
Peripheral Blood Stem Cell Transplantation
1
2010
35
0.320
Why?
Multiple Organ Failure
1
2010
122
0.300
Why?
Bone Marrow Transplantation
1
2010
301
0.290
Why?
Neoplasm Recurrence, Local
2
2021
1160
0.270
Why?
Child
14
2026
22693
0.260
Why?
Incidence
2
2025
2936
0.260
Why?
Siblings
2
2026
202
0.250
Why?
Cognition Disorders
2
2022
559
0.240
Why?
Wiskott-Aldrich Syndrome
1
2026
5
0.240
Why?
Tomography, X-Ray Computed
2
2013
2786
0.230
Why?
Child, Preschool
8
2026
11913
0.230
Why?
Infant
7
2026
10114
0.210
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2013
1998
0.200
Why?
Neoplasms
4
2021
2954
0.190
Why?
Agammaglobulinemia
1
2022
36
0.180
Why?
Lymphopenia
1
2022
62
0.180
Why?
Genetic Therapy
1
2024
303
0.180
Why?
Humans
26
2026
146342
0.180
Why?
Canada
1
2023
432
0.180
Why?
Prognosis
2
2025
4351
0.170
Why?
Retrospective Studies
7
2026
17438
0.170
Why?
Remission Induction
2
2013
308
0.170
Why?
Radiation Dosage
2
2013
193
0.170
Why?
Infant, Newborn
5
2024
6460
0.170
Why?
Immune Reconstitution
1
2021
10
0.160
Why?
Infertility
1
2021
62
0.160
Why?
Hypogonadism
1
2021
89
0.160
Why?
Follow-Up Studies
2
2025
5439
0.160
Why?
Pleural Effusion
1
2021
59
0.160
Why?
Testicular Neoplasms
1
2021
108
0.160
Why?
Endocrine System Diseases
1
2019
35
0.150
Why?
Renal Insufficiency
1
2021
173
0.150
Why?
Genotype
1
2024
1879
0.150
Why?
Interleukin-2 Receptor beta Subunit
1
2019
23
0.150
Why?
Adolescent
8
2026
22557
0.140
Why?
Prevalence
1
2025
2861
0.130
Why?
Hematologic Neoplasms
1
2020
170
0.130
Why?
Respiratory Insufficiency
1
2021
330
0.130
Why?
Male
12
2026
73396
0.130
Why?
Transplantation, Homologous
2
2026
416
0.130
Why?
Treatment Outcome
5
2026
11821
0.120
Why?
Vaccines
1
2021
389
0.110
Why?
Killer Cells, Natural
1
2019
481
0.110
Why?
Patient Reported Outcome Measures
1
2020
516
0.110
Why?
Female
10
2026
79499
0.110
Why?
Cost of Illness
1
2017
323
0.110
Why?
Leukemia, Myeloid, Acute
1
2021
702
0.100
Why?
Quality of Life
3
2022
3200
0.100
Why?
Radiopharmaceuticals
1
2013
210
0.090
Why?
Chemoradiotherapy
1
2013
238
0.090
Why?
Antineoplastic Agents
2
2021
2219
0.090
Why?
Karyotyping
1
2010
106
0.080
Why?
T-Lymphocytes
1
2019
2012
0.080
Why?
Histocompatibility Testing
1
2010
124
0.080
Why?
Bone Marrow
2
2022
310
0.080
Why?
Hodgkin Disease
1
2012
173
0.080
Why?
Longitudinal Studies
2
2023
3017
0.070
Why?
Neoplasm Staging
1
2013
1488
0.070
Why?
Receptors, Antigen, T-Cell
2
2022
677
0.070
Why?
Disease-Free Survival
1
2010
778
0.070
Why?
Body Mass Index
1
2017
2458
0.070
Why?
Heart Failure
1
2021
2329
0.070
Why?
Age Factors
2
2017
3347
0.070
Why?
Mutation
1
2019
4093
0.070
Why?
Cardiovascular Diseases
1
2019
2219
0.060
Why?
Recurrence
1
2010
1133
0.060
Why?
Cohort Studies
2
2016
6077
0.060
Why?
Cross-Sectional Studies
2
2020
5899
0.060
Why?
Monitoring, Immunologic
1
2026
25
0.060
Why?
Adult
7
2026
41087
0.060
Why?
Risk Factors
3
2020
10921
0.060
Why?
Comorbidity
1
2010
1665
0.060
Why?
Phenotype
2
2026
3206
0.050
Why?
Young Adult
4
2026
14330
0.050
Why?
Disease Progression
2
2022
2867
0.050
Why?
Tissue Donors
1
2026
425
0.050
Why?
Severity of Illness Index
1
2010
2921
0.050
Why?
Adenosine Deaminase
1
2022
45
0.040
Why?
Thymus Gland
1
2022
310
0.040
Why?
Neonatal Screening
1
2023
185
0.040
Why?
Immunologic Tests
1
2021
16
0.040
Why?
Blood Cell Count
1
2021
56
0.040
Why?
Transplant Recipients
1
2022
177
0.040
Why?
Proportional Hazards Models
1
2023
1331
0.040
Why?
Adaptive Immunity
1
2021
173
0.040
Why?
Cell Compartmentation
1
2019
51
0.040
Why?
Spleen
1
2021
503
0.040
Why?
Interleukin-15
1
2019
96
0.040
Why?
Homozygote
1
2019
197
0.040
Why?
Homeodomain Proteins
1
2022
525
0.030
Why?
Immunophenotyping
1
2019
324
0.030
Why?
Interleukin-2
1
2019
434
0.030
Why?
Neuropsychological Tests
1
2022
1149
0.030
Why?
Middle Aged
3
2020
36619
0.030
Why?
Cytomegalovirus Infections
1
2019
206
0.030
Why?
CD4-Positive T-Lymphocytes
1
2022
1150
0.030
Why?
CD8-Positive T-Lymphocytes
1
2022
931
0.030
Why?
Radiotherapy
1
2016
209
0.030
Why?
Immunity, Innate
1
2021
844
0.030
Why?
Survival Rate
1
2019
2092
0.030
Why?
Survival Analysis
1
2017
1378
0.030
Why?
Models, Molecular
1
2019
1574
0.030
Why?
Chronic Disease
1
2020
1827
0.030
Why?
Autoimmunity
1
2019
925
0.020
Why?
Case-Control Studies
1
2020
3647
0.020
Why?
Cell Proliferation
1
2019
2502
0.020
Why?
Prospective Studies
1
2022
8123
0.020
Why?
Surveys and Questionnaires
1
2020
6073
0.020
Why?
Time Factors
1
2017
7109
0.010
Why?
Signal Transduction
1
2019
5246
0.010
Why?
Aged
1
2020
26432
0.010
Why?
Eissa's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)